Canada markets closed

Agile Therapeutics, Inc. (AGRX)

OTC Markets OTCQB - OTC Markets OTCQB Delayed Price. Currency in USD
Add to watchlist
1.4500+0.0100 (+0.69%)
At close: 04:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
21,496
19,593
10,884
4,101
749
-
Cost of Revenue
8,655
8,978
6,836
10,718
282
-
Gross Profit
12,841
10,615
4,048
-6,617
467
-
Operating Expenses
Research Development
1,957
2,225
3,253
6,246
13,500
-
Selling General and Administrative
26,817
28,274
42,229
58,142
36,020
-
Total Operating Expenses
28,774
30,499
45,482
64,388
49,520
-
Operating Income or Loss
-15,933
-19,884
-41,434
-71,005
-49,053
-
Interest Expense
1,202
1,419
3,131
3,914
3,109
-
Total Other Income/Expenses Net
9,276
6,760
14,398
3,827
-
-
Income Before Tax
-7,791
-14,465
-30,087
-71,067
-51,853
-
Income Tax Expense
0
0
-4,675
0
0
-
Income from Continuing Operations
-7,791
-14,465
-25,412
-71,067
-51,853
-
Net Income
-7,791
-14,465
-25,412
-71,067
-51,853
-
Net Income available to common shareholders
-7,791
-14,465
-25,412
-71,067
-51,853
-
Basic EPS
7.31
-
-58.79
-1.46k
-1.22k
-760.00
Diluted EPS
7.31
-
-58.79
-1.46k
-1.22k
-760.00
Basic Average Shares
1,621
-
432.219
48.536
42.341
24.716
Diluted Average Shares
1,621
-
432.219
48.536
42.341
24.716